The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kuzmina U.Sh.

Bashkir State Medical University;
Institute of Biochemistry and Genetics

Tukhvatullin A.V.

Institute of Biochemistry and Genetics

Bakhtiyarova K.Z.

Bashkir State Medical University

Kutlubaev M.A.

Bashkir State Medical University

Lyutov O.V.

Bashkir State Medical University

Gizatullin T.R.

Republican Clinical Psychiatric Hospital

A clinical case of multiple sclerosis with an episode of schizophrenia-like syndrome

Authors:

Kuzmina U.Sh., Tukhvatullin A.V., Bakhtiyarova K.Z., Kutlubaev M.A., Lyutov O.V., Gizatullin T.R.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(4): 120‑124

DOI: 10.17116/jnevro2023123041120

Views: 3319

Downloaded: 69

Download PDF (RU)
Contact the author
Table of contents

A CLINICAL CASE OF MULTIPLE SCLEROSIS WITH AN EPISODE OF SCHIZOPHRENIA-LIKE SYNDROME
A CLINICAL CASE OF MULTIPLE SCLEROSIS WITH AN EPISODE OF SCHIZOPHRENIA-LIKE SYNDROME

To cite this article:

Kuzmina USh, Tukhvatullin AV, Bakhtiyarova KZ, Kutlubaev MA, Lyutov OV, Gizatullin TR. A clinical case of multiple sclerosis with an episode of schizophrenia-like syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(4):120‑124. (In Russ.)
https://doi.org/10.17116/jnevro2023123041120

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Close metadata
Recommended articles:
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57
Features of cognitive impairment in bipo­lar affe­ctive diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):15-19
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42
Features of primary forms of headache in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Neurofilament light chain: a diagnostic pote­ntial for multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):115-119
Controversial issues of diagnosis and theoretical concepts of schi­zophrenia in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):17-24
Psychological concepts — design of clinical models of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):25-31
Pharmacotherapy of schi­zophrenia: clinical and some age-related aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):41-50
Opti­cal cohe­rence tomo­graphy in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(3):59-68

The article presents a clinical observation of a schizophrenia-like disorder in a patient with multiple sclerosis (MS). The patient had highly active MS with a relapsing course, the diagnosis was made based on the McDonald 2017 criteria. During the course of a demyelinating disease of the nervous system, the patient developed an episode of psychotic disorders with symptoms of mutism, hallucinations, delusions and impaired thinking, which was quickly stopped in stationary conditions. This case is of particular interest to neurologists and psychiatrists, since psychotic disorders occur in MS patients and cause difficulties in diagnosis and treatment.

Keywords:

multiple sclerosis
schizophrenia
psychosis
comorbidity

Authors:

Kuzmina U.Sh.

Bashkir State Medical University;
Institute of Biochemistry and Genetics

Tukhvatullin A.V.

Institute of Biochemistry and Genetics

Bakhtiyarova K.Z.

Bashkir State Medical University

Kutlubaev M.A.

Bashkir State Medical University

Lyutov O.V.

Bashkir State Medical University

Gizatullin T.R.

Republican Clinical Psychiatric Hospital

Received:

03.11.2022

Accepted:

09.12.2022

List of references:

  1. Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Revue neurologique. 2016;172(1):3-13.  https://doi.org/10.1016/j.neurol.2015.10.006
  2. Mrykhina VV, Soldatkin VA, Khmaruk IN, et al. Mothers of schizophrenic patients: medical and psychological aspects of the problem. Medical Herald of the South of Russia. 2019;10(3):6-17. (In Russ.). https://doi.org/10.21886/2219-8075-2019-10-3-6-17
  3. Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophrenia Bulletin. 2006;32(2):200-202.  https://doi.org/10.1093/schbul/sbj052
  4. Gavin DP, Sharma RP. Histone modifications, DNA methylation, and schizophrenia. Neuroscience and Biobehavioral Reviews. 2010;34(6):882-888.  https://doi.org/10.1016/j.neubiorev.2009.10.010
  5. Andreassen OA, Harbo HF, Wang Y, et al. Psychiatric Genomics Consortium (PGC) Bipolar Disorder and Schizophrenia Work Groups; International Multiple Sclerosis Genetics Consortium (IMSGC), McEvoy LK, Desikan RS, Lie BA, Djurovic S, Dale AM. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Molecular Psychiatry. 2015 Feb;20(2):207-214.  https://doi.org/10.1038/mp.2013.195
  6. Langer-Gould A, Brara SM, Beaber BE, Zhang JL. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology. 2013;80(19):1734-1739. https://doi.org/10.1212/WNL.0b013e3182918cc2
  7. Arneth BM. Multiple Sclerosis and Schizophrenia. International Journal of Molecular Sciences. 2017 Aug 12;18(8):1760. https://doi.org/10.3390/ijms18081760
  8. Bjornevik K, Cortese M, Healy BC, Ascherio A. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296-301.  https://doi.org/10.1126/science.abj8222
  9. Rajda C, Bencsik K, Vécsei LL, et al. Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients. Journal of Neuroimmunology. 2011;124:93-100.  https://doi.org/10.1016/s0165-5728(02)00002-4
  10. Melnikov MV, Pashchenkov MV, Boĭko AN. Psychoneuroimmunology and multiple sclerosis. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2015;115(2-2):8-15. (In Russ.). https://doi.org/10.17116/jnevro2015115228-15
  11. Levite M, Marino F, Cosentino M. Dopamine, T cells and multiple sclerosis (MS). J Neural Transm (Vienna). 2017;124(5):525-542.  https://doi.org/10.1007/s00702-016-1640-4
  12. Li A, Zalesky A, Yue W, et al. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nature Medicine. 2020;26(4):558-565.  https://doi.org/10.1038/s41591-020-0793-8
  13. Ahangari M, Everest E, Nguyen TH, et al. Genome-wide analysis of schizophrenia and multiple sclerosis identifies shared genomic loci with mixed direction of effects. Brain, Behavior, and Immunity. 2022;104:183-190.  https://doi.org/10.1016/j.bbi.2022.06.007
  14. Meier UC, Ramagopalan SV, Goldacre MJ, et al. Risk of Schizophrenia and Bipolar Disorder in Patients With Multiple Sclerosis: Record-Linkage Studies. Frontiers in Psychiatry. 2020;11:662.  https://doi.org/10.3389/fpsyt.2020.00662
  15. Orlova VA, Serikova TM, Chernishchuk EN, et al. Concerning neurodegeneration in schizophrenia: data of spectral-dynamic analysis. Social Clin Psychiatry. 2010;20(2):67-79. (In Russ.).
  16. Vertkin AL, Rumyantsev MA, Skotnikov AS. Comorbidity. Clinical Medicine. 2012;90(10):4-11. (In Russ.).
  17. Zhulev SN, Toropova AA, Nemykin ON, et al. Clinical case of mental disorders in the debut of multiple sclerosis. Herald of the Northwestern State Medical University named after I.I. Mechnikov. 2017;9(3):114-120. (In Russ.).
  18. Lo Fermo S, Barone R, Patti F, et al. Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study. Multiple sclerosis. 2010;16(6):742-748.  https://doi.org/10.1177/1352458510365157
  19. Iakushina TI, Belova IuA. Psychotic disorders in multiple sclerosis. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2018;118(8-2):110-115. (In Russ.). https://doi.org/10.17116/jnevro2018118082110
  20. Tukhvatullin AV, Kuzmina USh, Utyagulova NF, et al. Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1S):15-20. (In Russ.). https://doi.org/10.14412/2074-2711-2021-1S-15-20
  21. Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, et al. The varieties of psychosis in multiple sclerosis: A systematic review of cases. Multiple sclerosis and Related Disorders. 2017;12:9-14.  https://doi.org/10.1016/j.msard.2016.12.012
  22. Fragoso YD, Frota ER, Lopes JS, et al. Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis. Clinical Neuropharmacology. 2010;33(6):312-316.  https://doi.org/10.1097/WNF.0b013e3181f8d513
  23. Kotov SV, Yakushina TI, Lizhdvoi VYu. Rebound phenomenon and restoration of multiple sclerosis activity upon discontinuation of fingolimod therapy. Russian Medical Journal. 2014;(22):1596-1599. (In Russ.).
  24. Mosolov SN. Actual theoretical problems of diagnostic, classification, neurobiology and therapy of schizophrenia: a comparison of International and Russian experience. Journal of Neurology and Psychiatry im. S.S. Korsakov. 2010;110(6):4-11. (In Russ.).
  25. Sabe M, Sentissi O. Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series. International Journal of Psychiatry in Clinical Practice. 2021 Sep 6:1-7.  https://doi.org/10.1080/13651501.2021.1973506
  26. Bertelsen A. Schizophrenia and related disorders: experience with current diagnostic systems. Psychopathology. 2002;35(2-3):89-93.  https://doi.org/10.1159/000065125

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.